Chinese scientists have developed a nanovaccine capable of preventing the formation of atherosclerotic plaques in arteries. The research was conducted by specialists from Nanjing University of Science and Technology and the University of Science and Technology of China, as reported by the South China Morning Post.
The vaccine operates on a two-component system: one set of nanoparticles carries an antigen that triggers an immune response, while the other enhances this process. According to the developers, this mechanism has proven effective in combating atherosclerosis.
Initial trials on laboratory mice have shown promising results, confirming the potential of this new approach. However, researchers emphasize the need for further studies to evaluate the long-term effectiveness of the treatment.
#space #science #educational #technology
